March 26 (Reuters) - BOD Australia Ltd (BDA) : PHASE I CLINICAL TRIAL DEMONSTRATES BOD'S PATENTED CBD WAFER SUPERIORITY Source text http://bit.ly/2Tvwthy (([email protected];))
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game